SP Clone Rabbit Monoclonal Antibodies by Spring Bioscience

1
(No Transcript)
2
Spring Bioscience utilizes a diverse knowledge
base for design input and keeps a strong focus on
IHC throughout the entire antibody development
process enabling us to deliver highly-defined and
consistent SP clones.
3
Spring Bioscience was acquired by Ventana Medical
Systems, Inc. (Ventana) in 2007 for its strong
development capabilities, and shortly thereafter
Ventana was acquired by Roche.
4
Spring Bioscience provides targeted high-value
product portfolio for cancer researchers,
including our line of SP Clone Rabbit Monoclonal
antibodies.
5
Spring Bioscience uses proprietary recombinant
technology to develop best-in-class rabbit
monoclonal antibodies.
6
(No Transcript)
7
(No Transcript)